Meetings & Events

What's New in Lipid Lowering Therapies?

June 17, 2021

Session Date and Time:

Friday, September 10
11:15 AM–12:00 PM EDT

Learning Objectives:

  1. Discuss the mechanism of action of new lipid-lowering pharmacotherapies.
  2. Review the indications for newer available lipid-lowering therapies, and discuss strategies for their use in primary and secondary prevention.
  3. Describe the pipeline of potential future lipid-lowering therapies.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Michael J. Blaha, MD, MPHDr. Blaha (Professor of Cardiology and Epidemiology) is the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Blaha has published over 500 scientific articles, with a focus on appropriate use of tests and new therapies in the prevention of atherosclerotic cardiovascular disease.

In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 20 trainees, many of which have gone on to hold prominent academic appointments. Clinically, he practices as a preventive cardiologist and in the interpretation of cardiac CT. His clinic specializes in patients with advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.